Ticker Details
Edwards Lifesciences Corp Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
IPO Date:	April 3, 2000
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$49.39B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.15 | 1.07%
Avg Daily Range (30 D):	$1.17 | 1.45%
Avg Daily Range (90 D):	$1.00 | 1.23%

Institutional Daily Volume
Avg Daily Volume:	1.5M
Avg Daily Volume (30 D):	4.3M
Avg Daily Volume (90 D):	3.9M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	29,230
Avg Institutional Trade:	$6.18M
Avg Institutional Trade (30 D):	$7.38M
Avg Institutional Trade (90 D):	$7.53M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$22.58M
Avg Closing Trade (30 D):	$65M
Avg Closing Trade (90 D):	$62.75M
Avg Closing Volume:	410.38K

News

Apr 24, 2026 @ 4:50 PM Edwards Lifesciences Stock Surges On Heart Valve D... Source: Vandana Singh

Feb 20, 2026 @ 5:02 AM ORBIMED Advisors Trims $125 Million Terns Stake Af... Source: Eric Trie

Feb 17, 2026 @ 9:00 AM Pulmonary Artery Catheter Market Size to Reach USD... Source: Sns Insider

Jan 15, 2026 @ 1:42 PM Boston Scientific Acquires Penumbra In $14.5 Billi... Source: Akanksha Bakshi

Jan 12, 2026 @ 2:31 PM Court Ruling Ends Edwards Lifesciences $1.2 Billio... Source: Vandana Singh

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.89	$.66	$.16
Diluted EPS	$1.88	$.66	$.16
Revenue	$6.3B	$1.65B	$1.57B
Gross Profit	$4.91B	$1.29B	$1.23B
Net Income / Loss	$1.09B	$380.7M	$91.2M
Operating Income / Loss	$1.35B	$477.6M	$151.1M
Cost of Revenue	$1.4B	$362.6M	$343M
Net Cash Flow	$-701.3M	$-492M	$244.7M
PE Ratio

Splits
Jun 01, 2020	3:1
Dec 14, 2015	2:1
May 28, 2010	2:1